Effects of Portulaca oleracea L. Polysaccharides on Phenotypic and Functional Maturation of Murine Bone Marrow Derived Dendritic Cells

Nutrition and Cancer

Volumn 67, Issue 6, 2015, Pages 987-993

  Zhao, Rui ^a   Zhang, Tao ^b   Zhao, Hui ^c   Cai, Yaping ^a  

^a HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

^c Spice Limited Company of Shanghai Pan Tian Tinglin Town   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PORTULACA OLERACEA; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; DENDRITIC CELL; DRUG EFFECTS; FEMALE; METABOLISM; NEOPLASMS; PORTULACA; TUMOR CELL LINE;

MURINAE; PORTULACA OLERACEA;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; NEOPLASMS; PHENOTYPE; POLYSACCHARIDES; PORTULACA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939654936     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1060352     Document Type: Article

References (26)

1. Pagliusi S and World Health Organization: Human Papillomavirus Infection and Cervical Cancer (Slide 14), 2006. Retrieved from http://www. who.int/vaccine-research/diseases/hpv/en/.
2. Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, et al.: Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. J Cancer Res Clin Oncol 129, 511-520, 2003.
3. Santin AD, Bellone S, Palmieri M, Zanolini A, Ravaggi A, et al.: Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial. J Virol 82, 1968-1979, 2008.
4. Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MN, et al.: The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak. J Ethnopharmacol 73, 445-451, 2000.
5. Dkhil MA, Abdel Moniem AE, Al-Quraishy S, and Saleh RA: Antioxidant effect of purslane (Portulaca oleracea) and its mechanism of action. J Med Plants Res 5, 1563-1589, 2011.
6. Rashed AN, Afifi FU, and Disi AM: Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol 88, 131-136, 2003.
7. Chen T, Zhu L, Liu XY, Li YY, Zhao CD, et al.: Synthesis and antioxidant activity of phosphorylated polysaccharide from Portulaca oleracea L. with H3PW12O40 immobilized on polyamine functionalized polystyrene bead as catalyst. J Mol Catal A: Chem 342, 74-82, 2011.
8. Zhao R, Cai Y, and Chen Z: Anti-uterine cervix cancer study of polysaccharide from portulace oleracea L. on aged tumor-bearing mice. Chinese Journal of Gerontology 9, 4480-4482, 2013.
9. Zhao R, Gao X, Cai Y, Shao XY, Jia GY, et al.: Antitumor activity of Portulaca oleracea L. polysaccharides against. Carbohyd Polym 96, 376-383, 2013.
10. Steinman RM and Banchereau J: Taking dendritic cells into medicine. Nature 449, 419-426, 2007.
11. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, et al.: Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 163, 3920-3927, 1999.
12. Li X, He X, Liu B, Xu L, Lu C, et al.: Maturation of murine bone marrow derived dendritic cells induced by radix glycyrrhizae polysaccharide. Molecules 17, 6557-6568, 2012.
13. Huang D, Nie S, Jiang L, and Xie M: A novel polysaccharide from the seeds of Plantago asiatica L. induces dendritic cells maturation through toll-like receptor 4. Int Immunopharmacol 18, 236-243, 2014.
14. Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y, et al.: A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma. J Hematol Oncol 7, 15, 2014.
15. Ji B, Chen Q, and Liu B: Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma. Yonsei Med J 54, 92-100, 2013.
16. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, et al.: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184, 1413-1424, 1996.
17. Sadeghi L, Kamali-Sarvestani E, Azarpira N, Shariati M, and Karimi MH: Immunomodulatory effects of mice mesenchymal stem cells on maturation and activation ofdendritic cells. Iran J Immunol 11, 177-188, 2014.
18. Tzianabos AO: Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13, 523-533, 2000.
19. Han JCH, Yu YSH, Tang ZHH, and Zang GQ.: Effect of astragalus polysaccharide on differentiation and maturation of dendritic cells in vitro. Shanghai Med J 12, 873-876, 2006.
20. Xu Z and Shan Y.: Anti-fatigue effects of polysaccharides extracted from Portulaca oleracea L. inmice. Indian J Biochem Biophys 51, 321-325, 2014.
21. Dong CX, Hayashi K, Lee JB, and Hayashi T.: Characterization of structures and antiviral effects of polysaccharides from Portulaca oleracea L. Chem Pharm Bull 58, 507-510, 2010.
22. Lee SJ, Noh KT, Kang TH, Han HD, Shin SJ, et al.: The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4. BMB Rep 47, 115-120, 2014.
23. Brangerr J, Knapp S, Weijer S, Leemans JC, Pater JM, et al.: Role of tolllike receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun 72, 788-794, 2004.
24. Trinchieri G: Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 70, 83-243, 1998.
25. Gumperz JE: CD, 1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses? J Leukoc Biol 76, 307-313, 2004.
26. Xie J, Qian J, Wang S, Freeman ME, Epstein J, et al.: Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated Proteinkinase p38. J Immunol 171, 4792-4800, 2003.